₹ 0.3 Cr
Volume Transacted
(Dec 11, 2024)
2.1 K
Stocks Traded
(Dec 11, 2024)
Last Updated on: Dec 11, 2024
Suven Pharmaceuticals Ltd
NSE: SUVENPHAR
ISIN
INE03QK01018
Last updated on: Dec 11, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Suven Pharmaceuticals Ltd
NSE: SUVENPHAR
Share Price
₹ 1296.85
3.00 (0.23%)
Last updated on: Dec 11, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
11 Dec 2024 | 1296.85 | 1288 | 1304.85 | 1287.75 |
10 Dec 2024 | 1293.85 | 1306.05 | 1306.3 | 1272.05 |
09 Dec 2024 | 1307.8 | 1321 | 1337.85 | 1283.65 |
06 Dec 2024 | 1305.3 | 1322.2 | 1322.2 | 1284.25 |
05 Dec 2024 | 1295.15 | 1306.5 | 1310 | 1285 |
04 Dec 2024 | 1299.4 | 1316.7 | 1317.85 | 1288.85 |
03 Dec 2024 | 1290.55 | 1304.2 | 1304.2 | 1283.65 |
02 Dec 2024 | 1307.95 | 1303.9 | 1359 | 1303.9 |
29 Nov 2024 | 1303.85 | 1274.95 | 1327.55 | 1274.95 |
28 Nov 2024 | 1274.9 | 1284.25 | 1284.25 | 1254.25 |
Date | Price (₹) |
---|---|
11 Dec 2024 | 1296.85 |
10 Dec 2024 | 1293.85 |
09 Dec 2024 | 1307.8 |
06 Dec 2024 | 1305.3 |
05 Dec 2024 | 1295.15 |
04 Dec 2024 | 1299.4 |
03 Dec 2024 | 1290.55 |
02 Dec 2024 | 1307.95 |
29 Nov 2024 | 1303.85 |
28 Nov 2024 | 1274.9 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 11 Dec 9.00 AM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Suven Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Suven Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Suven Pharmaceuticals strengths its ADC offering with acquisition of NJ Bio
Suven Pharmaceuticals announced the acquisition of a controlling stake in NJ Bio Inc. (NJ ...
07 Dec 2024 11:24
Suven Pharmaceuticals to acquire majority stake in US based NJ Bio
Suven Pharmaceuticals has executed definitive agreements today, i.e. 07 December 2024, for...
07 Dec 2024 11:20
Suven Pharma to acquire majority stake in US-based NJ Bio
The $64.4 million deal includes both primary equity infusion and secondary acquisition. As...
07 Dec 2024 17:20
Suven Pharmaceuticals Ltd Surges 4.23%
Suven Pharmaceuticals Ltd gained 4.23% today to trade at Rs 1359. The BSE Healthcare index...
02 Dec 2024 09:30
Suven Pharma gains as PAT rises to Rs 82 crore in Q2
The revenue growth was driven by Pharma CDMO business and Sapala acquisition. The company ...
13 Nov 2024 11:49
Suven Pharmaceuticals to conduct EGM
Suven Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...
30 Oct 2024 14:53
Unlimited trading starting at just Rs. 249*